At what platelet count (per microliter) should heparin be held?

Heparin Should Be Held When Platelet Count Falls Below 100,000/μL

If the platelet count falls below 100,000/mm³ or if recurrent thrombosis develops, promptly discontinue heparin and evaluate for heparin-induced thrombocytopenia (HIT). 1

Critical Thresholds for Heparin Management

Immediate Discontinuation Required

• Platelet count <100,000/μL: Stop heparin immediately and evaluate for HIT 1
• ≥50% drop from baseline: Even if absolute count remains >100,000/μL, this warrants heparin discontinuation and HIT evaluation 2, 3

Context-Specific Considerations

For Cancer-Associated Thrombosis with Thrombocytopenia:

• Platelet ≥50,000/μL: Full therapeutic anticoagulation without modification 4
• Platelet 25,000-50,000/μL: Reduce LMWH to 50% therapeutic dose or use prophylactic dosing 4
• Platelet <25,000/μL: Temporarily discontinue anticoagulation 4
• Acute high-risk VTE with platelets <50,000/μL: Consider full-dose anticoagulation with platelet transfusion support to maintain platelets ≥40-50,000/μL 4

For Acute Coronary Syndrome with Thrombocytopenia:

• Platelet >50,000/μL: Standard anticoagulant response expected 5
• Platelet <50,000/μL: Reduced heparin doses (30-50 units/kg) may be required 5

Monitoring Requirements

High-Risk Populations (Surgical/Trauma Patients on UFH):

• Check platelet count at baseline before starting heparin
• Monitor at least every other day from day 4 through day 14 2
• If recent heparin exposure (within 30 days): Begin monitoring on day 0 2

Intermediate-Risk Populations (Medical Patients on UFH, Post-Surgical LMWH):

• Monitor platelet count every 2-3 days from day 4 through day 14 2

Low-Risk Populations (Medical/Obstetric Patients on LMWH):

• Routine monitoring not required, but check if clinical suspicion arises 2

When HIT is Suspected (4Ts Score ≥4)

1. Stop all heparin immediately (including heparin flushes)
2. Do NOT transfuse platelets prophylactically 3
3. Start alternative anticoagulation at full therapeutic doses unless contraindicated:
   • Argatroban
   • Bivalirudin
   • Fondaparinux
   • Danaparoid (where available)
4. Do NOT start warfarin until platelet count recovers to >150,000/μL 3
5. Order HIT antibody testing (immunoassay preferred initially) 2

Common Pitfalls to Avoid

• Never assume thrombocytopenia is "dilutional" without excluding HIT—this delay can be fatal
• Do not wait for HIT antibody results before stopping heparin if clinical suspicion is intermediate-to-high
• Avoid platelet transfusions in suspected HIT as they may paradoxically worsen thrombosis risk
• Remember rapid-onset HIT: Patients with heparin exposure in the past 100 days can develop thrombocytopenia within 24 hours of re-exposure 2, 3
• Check for pseudothrombocytopenia by repeating count in citrate or heparin tube if initial drop seems unexpected 6

The 100,000/μL threshold is the FDA-mandated cutoff for heparin discontinuation, representing the point where bleeding risk from thrombocytopenia intersects with the prothrombotic risk of potential HIT.